rectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Histologically verified adenocarcinoma of the rectum within 15 cm of the anal verge, = 6 months -Patients who are unfit for surgical treatment, due to co-morbidity, or patients who refuse surgery -WHO
Exclusion criteria
Exclusion criteria: -Pregnant women -Patients with any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the feasibility and the maximum tolerated radiation dose in HDRBT of the rectum after EBRT in rectal cancer patients who are unfit for surgery or refuse surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| *To determine the incidence and severity of acute and late toxicity of EBRT followed by HDRBT *To determine the patient*s sphincter function *To determine the clinical tumor response of EBRT followed by HDRBT *To correlate the isodose lines of the irradiated tumor and normal tissue volumes with toxicity (HDRBT) | — |
Countries
Netherlands